Archer-Daniels-Midland Company ADM
Composite 46/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 30/100 — a moderate mark against it.
Momentum ranks 68/100 — a moderate point in its favour. Income ranks 66/100 — a moderate point in its favour. Balance-sheet strength ranks 51/100 — a slight point in its favour.
Quality ranks 30/100 — a moderate mark against it. Growth ranks 33/100 — a moderate mark against it. Valuation ranks 49/100 — a slight mark against it.
What the company does Archer-Daniels-Midland (ADM) processes agricultural commodities into food, feed, energy, and industrial ingredients across three segments: Ag Services and Oilseeds; Carbohydrate Solutions; and Nutrition. Its global network spans origination, storage, crushing, milling, and specialty ingredient production, serving customers in human and animal nutrition.
Key financials ADM’s trailing margins are weak: gross 6.9%, operating 4.0%, net 2.2%. Profitability metrics are below average: ROE 7.6%, ROA 2.3%. Revenue and EPS growth are negative at -6.2% and -38.6%, respectively. Leverage is moderate with debt/equity at 0.39 and net debt/EBITDA at 2.75.
Stock health Momentum is mixed: 12-month +33.83%, 6-month +19.64%, but -7.24% from the 52-week high. Sideravia scores show poor quality (28.9) but strong momentum (66.9) and income (67.3). Dividend yield is 2.6% with a 47.7% payout ratio.
Price vs fair value ADM trades at a PREMIUM of 3.50% versus the analyst mean target of 78.70. - Trump’s reported push to shield farmers from biofuel waivers may support ethanol-linked demand (2026-08-30). - Analysts note ADM’s cash flow looks below fair value while earnings appear above fair value (2026-08-28). - Q2 beat was reported, but questions remain about valuation (2026-08-27). - Pivot into natural ingredients and precision fermentation cited as a potential long-term catalyst (2026-08-27).
Looking forward Forward P/E of 16.50 and PEG of 0.45 suggest improved earnings outlook, though current profitability remains weak. The stock’s premium reflects momentum and income appeal, offset by weak quality and earnings headwinds.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.